Key Events This Week
15 Sep: Vineet Laboratories Ltd hits lower circuit amid heavy selling pressure
16 Sep: Valuation shifts signal changing market sentiment
18 Sep: Week closes at ₹36.45 (-1.38%)

Vineet Laboratories Ltd is Rated Sell
2026-09-17 10:10:04Vineet Laboratories Ltd is rated Sell by MarketsMOJO, with this rating last updated on 01 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and technical outlook.
Read full news article
Vineet Laboratories Ltd Valuation Shifts Signal Changing Market Sentiment
2026-09-16 08:01:54Vineet Laboratories Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. This change, coupled with its current price performance and peer comparisons, suggests a recalibration of price attractiveness for investors within the Pharmaceuticals & Biotechnology sector.
Read full news article
Below All Moving Averages and Now at Lower Circuit: Vineet Laboratories Ltd Loses 3.3% in a Single Session
2026-09-15 10:00:31At Rs 35.17, sellers were still queuing — but there were no buyers willing to take the other side. Vineet Laboratories Ltd locked at its lower circuit of 5% on 15 Sep 2026, with unfilled sell orders and a frozen price, signalling persistent selling pressure in a micro-cap stock.
Read full news article
Vineet Laboratories Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent
2026-09-11 10:00:23At Rs 37.57, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Vineet Laboratories Ltd locked at its upper circuit of 5% on 11 Sep 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
Vineet Laboratories Ltd Locks at Upper Circuit With 0.7% Gain — Buyers Queue, Sellers Absent
2026-09-09 10:00:28At Rs 38.78, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Vineet Laboratories Ltd locked at its upper circuit of 5% on 9 Sep 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
Vineet Laboratories Ltd is Rated Sell
2026-09-04 10:10:05Vineet Laboratories Ltd is rated Sell by MarketsMOJO, with this rating last updated on 01 April 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 04 September 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Vineet Laboratories Ltd Locks at Lower Circuit With 3.45% Loss — Sellers Queue, No Buyers in Sight
2026-09-01 10:00:32At Rs 36.92, sellers were still queuing — but there were no buyers willing to take the other side. Vineet Laboratories Ltd locked at its lower circuit of 3.45% on 1 Sep 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a micro-cap stock with limited liquidity.
Read full news article
Vineet Laboratories Ltd Valuation Shifts Signal Expensive Pricing Amid Mixed Returns
2026-08-27 08:01:32Vineet Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from a risky to an expensive rating. This article analyses the recent changes in key valuation metrics such as the price-to-earnings (P/E) ratio and price-to-book value (P/BV), comparing them with historical trends and peer averages to assess the stock’s price attractiveness.
Read full news article





